• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    CEVA (CEVA) Lands AI Licensing Deal On A Fair Value Story That Still Has To Deliver

    Simply Wall St·07/16/2026 16:36:09
    Listen to the news

    AI licensing deal reframes CEVA stock story

    CEVA (CEVA) has drawn fresh attention after announcing a landmark AI licensing agreement with a major U.S. software and AI platform company focused on custom silicon for next generation intelligent computing devices.

    The customer selected CEVA's NeuPro-M neural processing unit IP to handle on device generative, multimodal and emerging agentic AI workloads within tight power, area and thermal limits, extending CEVA's reach beyond its traditional semiconductor and device manufacturer clients.

    See our latest analysis for CEVA.

    CEVA's latest AI licensing deal lands at a time when the stock has surged, with a 90 day share price return of 87.74% and a 1 year total shareholder return of 84.04%. However, shorter term share price momentum has recently cooled.

    If this kind of AI hardware story interests you, it could be worth widening your watchlist using Simply Wall St's screener for 52 AI infrastructure stocks

    After CEVA's sharp rerating on the AI deal, the bullish story leans on future licensing potential, while the bear case points to current losses and the recent COO change. The key question is which side the valuation actually supports.

    Most Popular Narrative: 14.1% Undervalued

    With CEVA last closing at $41.96 against a narrative fair value of $48.88, the current setup frames a clear valuation gap that hinges on how its AI and connectivity licensing story plays out.

    Accelerating customer adoption of CEVA's Edge AI NPUs (as evidenced by multiple new, high-impact licensing deals and the integration of NeuPro architectures across diverse markets like audio, video, and infrastructure) lays the foundation for materially higher royalty revenue per device as these AI-enabled products ramp into mass production over the next 18 to 24 months.

    Read the complete narrative.

    Want to see what sits behind that royalty story for CEVA? The narrative leans on brisk revenue growth, rising margins and a punchy future earnings multiple. Curious which specific financial milestones and timing assumptions have to fall into place for that fair value to hold up?

    Result: Fair Value of $48.88 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, CEVA's story still hinges on turning its current net loss of $11.77 million into sustained profitability, while managing customer concentration and sector wide volatility that could pressure royalties and licensing demand.

    Find out about the key risks to this CEVA narrative.

    Another View: CEVA looks expensive on sales multiples

    The fair value narrative suggests CEVA is 14.1% undervalued at $41.96 versus $48.88, but the P/S picture tells a tougher story. CEVA trades on a 10.4x P/S ratio, richer than the US Semiconductor industry at 7.9x and peer average at 7.6x, even though the fair ratio sits higher at 11x. In practical terms, the current price already bakes in a premium versus sector and peers, with only a small cushion to the fair ratio. This leaves less room if growth or margins fall short. Which signal would you trust more: the optimistic fair value or the relatively full sales multiple?

    See what the numbers say about this price — find out in our valuation breakdown.

    NasdaqGS:CEVA P/S Ratio as at Jul 2026
    NasdaqGS:CEVA P/S Ratio as at Jul 2026

    Next Steps

    Given the mixed signals around CEVA, it makes sense to look at the full picture yourself and decide how much risk and reward you are comfortable with, starting with the 1 key reward and 2 important warning signs.

    Looking for more investment ideas beyond CEVA?

    CEVA's setup might be interesting, but you do not want to rely on one stock when there are plenty of other potential ideas worth checking on your radar.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.